{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T01:51:07Z","timestamp":1781833867167,"version":"3.54.5"},"reference-count":47,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T00:00:00Z","timestamp":1775260800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173862"],"award-info":[{"award-number":["82173862"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009601","name":"Beijing Municipal Administration of Hospitals","doi-asserted-by":"publisher","award":["DFL20221402"],"award-info":[{"award-number":["DFL20221402"]}],"id":[{"id":"10.13039\/501100009601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.isci.2026.115641","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T07:48:37Z","timestamp":1775634517000},"page":"115641","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Oral milk exosome-PLGA nanoparticles enhance anti-tuberculosis efficacy of PBTZ169 and bedaquiline"],"prefix":"10.1016","volume":"29","author":[{"given":"Eryue","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chennan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangxue","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zimo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.115641_bib1","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1186\/s12889-024-20664-w","article-title":"Global, regional, and national burden of tuberculosis and attributable risk factors for 204 countries and territories, 1990-2021: a systematic analysis for the Global Burden of Diseases 2021 study","volume":"24","author":"Yang","year":"2024","journal-title":"BMC Public Health"},{"key":"10.1016\/j.isci.2026.115641_bib2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1164\/rccm.202410-2096ST","article-title":"Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS\/CDC\/ERS\/IDSA Clinical Practice Guideline","volume":"211","author":"Saukkonen","year":"2025","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.isci.2026.115641_bib3","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01314-18","article-title":"In Vitro Activity of PBTZ169 against Multiple Mycobacterium Species","volume":"62","author":"Shi","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.isci.2026.115641_bib4","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/emmm.201303575","article-title":"Towards a new combination therapy for tuberculosis with next generation benzothiazinones","volume":"6","author":"Makarov","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.isci.2026.115641_bib5","doi-asserted-by":"crossref","first-page":"14526","DOI":"10.1021\/acs.jmedchem.1c01049","article-title":"Structural and Activity Relationships of 6-Sulfonyl-8-Nitrobenzothiazinones as Antitubercular Agents","volume":"64","author":"Fan","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.isci.2026.115641_bib6","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1021\/acsmedchemlett.7b00106","article-title":"Identification of Better Pharmacokinetic Benzothiazinone Derivatives as New Antitubercular Agents","volume":"8","author":"Lv","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.isci.2026.115641_bib7","doi-asserted-by":"crossref","first-page":"5315","DOI":"10.1128\/AAC.01418-13","article-title":"Population Pharmacokinetics of Bedaquiline (TMC207), a Novel Antituberculosis Drug","volume":"58","author":"McLeay","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.isci.2026.115641_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122229","article-title":"Determining the solubilities for benzoate, nicotinate, hydrochloride, and malonate salts of bedaquiline","volume":"627","author":"Okezue","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.isci.2026.115641_bib9","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.fct.2017.12.022","article-title":"Supramolecular strategy for reducing the cardiotoxicity of bedaquiline without compromising its antimycobacterial efficacy","volume":"119","year":"2018","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.isci.2026.115641_bib10","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1177\/2040622315582325","article-title":"Bedaquiline for the treatment of multidrug-resistant tuberculosis: great promise or disappointment?","volume":"6","author":"Field","year":"2015","journal-title":"Ther. Adv. Chronic Dis."},{"key":"10.1016\/j.isci.2026.115641_bib11","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1021\/acsmedchemlett.7b00196","article-title":"6-Cyano Analogues of Bedaquiline as Less Lipophilic and Potentially Safer Diarylquinolines for Tuberculosis","volume":"8","author":"Tong","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.isci.2026.115641_bib12","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/postgradmedj-2020-138661","article-title":"Managing drug-induced QT prolongation in clinical practice","volume":"97","author":"Khatib","year":"2021","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.isci.2026.115641_bib13","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/jac\/dkh411","article-title":"Lectin-functionalized poly (lactide-co-glycolide) nanoparticles as oral\/aerosolized antitubercular drug carriers for treatment of tuberculosis","volume":"54","author":"Sharma","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.isci.2026.115641_bib14","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","article-title":"PLGA-based nanoparticles: An overview of biomedical applications","volume":"161","author":"Danhier","year":"2012","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.isci.2026.115641_bib15","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jconrel.2023.05.043","article-title":"Yeast cell membrane-camouflaged PLGA nanoparticle platform for enhanced cancer therapy","volume":"359","author":"He","year":"2023","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.isci.2026.115641_bib16","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3390\/ijms22031105","article-title":"Bovine Milk-Derived Exosomes as a Drug Delivery Vehicle for miRNA-Based Therapy","volume":"22","author":"Del Pozo-Acebo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.115641_bib17","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.canlet.2015.10.020","article-title":"Bovine milk-derived exosomes for drug delivery","volume":"371","author":"Munagala","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.isci.2026.115641_bib18","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.nano.2015.10.012","article-title":"Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells","volume":"12","author":"Kim","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/j.isci.2026.115641_bib19","article-title":"Milk-derived exosomes as a promising vehicle for oral delivery of hydrophilic biomacromolecule drugs","volume":"18","author":"Li","year":"2023","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.isci.2026.115641_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2024.139034","article-title":"Enhanced antibacterial activity of bovine milk exosome-based drug formulation against bacterial pathogens","volume":"447","author":"Xu","year":"2024","journal-title":"Food Chem."},{"key":"10.1016\/j.isci.2026.115641_bib21","doi-asserted-by":"crossref","first-page":"21091","DOI":"10.1021\/acsnano.4c02560","article-title":"Milk Exosome-Liposome Hybrid Vesicles with Self-Adapting Surface Properties Overcome the Sequential Absorption Barriers for Oral Delivery of Peptides","volume":"18","author":"Xiao","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.isci.2026.115641_bib22","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.xphs.2018.11.022","article-title":"The Potential of Exosomes From Cow Milk for Oral Delivery","volume":"108","author":"Betker","year":"2019","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.isci.2026.115641_bib23","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.jff.2017.05.009","article-title":"Milk miRNAs encapsulated in exosomes are stable to human digestion and permeable to intestinal barrier in vitro","volume":"34","author":"Rani","year":"2017","journal-title":"J. Funct.Foods"},{"key":"10.1016\/j.isci.2026.115641_bib24","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1080\/10717544.2021.2023699","article-title":"Milk exosomes-mediated miR-31-5p delivery accelerates diabetic wound healing through promoting angiogenesis","volume":"29","author":"Yan","year":"2022","journal-title":"Drug Deliv."},{"key":"10.1016\/j.isci.2026.115641_bib25","doi-asserted-by":"crossref","first-page":"16069","DOI":"10.1021\/acs.jafc.2c04971","article-title":"Milk Exosomes Facilitate Oral Delivery of Drugs against Intestinal Bacterial Infections","volume":"70","author":"Qu","year":"2022","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.isci.2026.115641_bib26","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-023-02176-8","article-title":"Potential therapeutic effects of milk-derived exosomes on intestinal diseases","volume":"21","author":"Cui","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.isci.2026.115641_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24065202","article-title":"Tuberculosis: Pathogenesis, Current Treatment Regimens and New Drug Targets","volume":"24","author":"Alsayed","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.115641_bib28","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00840-18","article-title":"Optimized Background Regimen for Treatment of Active Tuberculosis with the Next-Generation Benzothiazinone Macozinone (PBTZ169)","volume":"62","author":"Lupien","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.isci.2026.115641_bib29","article-title":"Targeting the Heart of Mycobacterium: Advances in Anti-Tubercular Agents Disrupting Cell Wall Biosynthesis","volume":"18","author":"Diab","year":"2025","journal-title":"Pharm. Basel Switz."},{"key":"10.1016\/j.isci.2026.115641_bib30","article-title":"Verapamil and its metabolite norverapamil inhibit the Mycobacterium tuberculosis MmpS5L5 efflux pump to increase bedaquiline activity","volume":"122","author":"Fountain","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2026.115641_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116829","article-title":"Design, synthesis and antimycobacterial activity of novel benzothiazinones with improved water solubility","volume":"279","author":"Zhong","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.isci.2026.115641_bib32","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1080\/10717544.2021.1938756","article-title":"PLGA-based biodegradable microspheres in drug delivery: recent advances in research and application","volume":"28","author":"Su","year":"2021","journal-title":"Drug Deliv."},{"key":"10.1016\/j.isci.2026.115641_bib33","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1002\/cmdc.202000419","article-title":"The Critical Role of Passive Permeability in Designing Successful Drugs","volume":"15","author":"Di","year":"2020","journal-title":"ChemMedChem"},{"key":"10.1016\/j.isci.2026.115641_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.05.024","article-title":"Physical methods for enhancing drug absorption from the gastrointestinal tract","volume":"175","author":"Luo","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.isci.2026.115641_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmpk.2022.100488","article-title":"Food effects on gastrointestinal physiology and drug absorption","volume":"48","author":"Kambayashi","year":"2023","journal-title":"Drug Metabol. Pharmacokinet."},{"key":"10.1016\/j.isci.2026.115641_bib36","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/j.apsb.2021.12.015","article-title":"Milk-derived exosomes exhibit versatile effects for improved oral drug delivery","volume":"12","author":"Wu","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.isci.2026.115641_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201700082","article-title":"Human milk exosomes and their microRNAs survive digestion in vitro and are taken up by human intestinal cells","volume":"61","author":"Liao","year":"2017","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.isci.2026.115641_bib38","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1021\/acsbiomaterials.5c00419","article-title":"Internal Water-Induced Acceleration, Chemical Pathways, and Contributing Factors in the Degradation of Poly(lactic-co-glycolic acid) (PLGA) Microparticles and Devices","volume":"11","author":"Mayer","year":"2025","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.isci.2026.115641_bib39","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1021\/bm050228k","article-title":"How autocatalysis accelerates drug release from PLGA-based microparticles: a quantitative treatment","volume":"6","author":"Siepmann","year":"2005","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.isci.2026.115641_bib40","first-page":"1847","article-title":"Bile salts-containing vesicles: promising pharmaceutical carriers for oral delivery of poorly water-soluble drugs and peptide\/protein-based therapeutics or vaccines","volume":"23","author":"Aburahma","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.isci.2026.115641_bib41","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.nano.2017.03.001","article-title":"Milk-derived exosomes for oral delivery of paclitaxel","volume":"13","author":"Agrawal","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.isci.2026.115641_bib42","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/aps.2016.37","article-title":"Ergosterol-loaded poly(lactide-co-glycolide) nanoparticles with enhanced in vitro antitumor activity and oral bioavailability","volume":"37","author":"Zhang","year":"2016","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.isci.2026.115641_bib43","first-page":"95","article-title":"Manufacturing of Proteins and Antibodies: Chapter Downstream Processing Technologies","volume":"165","author":"Turner","year":"2018","journal-title":"Adv. Biochem. Eng. Biotechnol."},{"key":"10.1016\/j.isci.2026.115641_bib44","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/03639045.2018.1539743","article-title":"Efficient method for isolation of exosomes from raw bovine milk","volume":"45","author":"Yamauchi","year":"2019","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.isci.2026.115641_bib45","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.ijpharm.2017.11.017","article-title":"Relationship between polarities of antibiotic and polymer matrix on nanoparticle formulations based on aliphatic polyesters","volume":"548","author":"Ritsema","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.isci.2026.115641_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.123920","article-title":"A quality-by-design strategic approach for the development of bedaquiline-pretomanid nanoparticles as inhalable dry powders for TB treatment","volume":"653","author":"Patil","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.isci.2026.115641_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.1009338","article-title":"The role of milk-derived exosomes in the treatment of diseases","volume":"13","author":"Rashidi","year":"2022","journal-title":"Front. Genet."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226010163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226010163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T01:04:20Z","timestamp":1781831060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226010163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2589004226010163"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.115641","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral milk exosome-PLGA nanoparticles enhance anti-tuberculosis efficacy of PBTZ169 and bedaquiline","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.115641","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115641"}}